Harrison Global Holdings Board Ratifies $64M Acquisitions Despite No Prior Due Diligence, Citing Significant Risks
Summary
Harrison Global Holdings' board ratified two equity acquisitions totaling $64 million, approximately ten times its market capitalization, despite acknowledging a lack of comprehensive due diligence and significant financial and operational risks prior to execution.
Key Events
-
Board Ratifies $64 Million Acquisitions
On March 26, 2026, the board approved and ratified the acquisition of a 40% equity interest in U Bio Science Co., Ltd. and a 100% equity interest in Gemtech Co., Ltd., for a total consideration of US$64,000,000.
-
Lack of Pre-Closing Due Diligence
The board acknowledged that comprehensive financial, legal, tax, and operational due diligence was not completed prior to the execution of the share purchase agreements, and no independent valuation was presented.
-
Conditional Approval and Post-Closing Audit Mandated
The approval was conditional, subject to further verification and review. The board directed a comprehensive post-closing special audit of the target companies and authorized management to take remedial actions if material issues are identified.
-
Significant Financial and Operational Risks Acknowledged
The board recognized that these transactions involve significant financial, legal, and operational risks, with potential limitations on the enforceability of contractual rights.
Analysis
Harrison Global Holdings' board has ratified two equity acquisitions totaling $64 million, a sum approximately ten times the company's current market capitalization. This decision is highly concerning as the board explicitly acknowledged that comprehensive financial, legal, tax, and operational due diligence was not completed prior to the execution of the agreements, and no independent valuation was presented. The board's approval is conditional, mandating a post-closing special audit and authorizing management to pursue remedial actions, including renegotiation or enforcement of rights, if material issues are found. This situation raises significant red flags regarding corporate governance, financial prudence, and the potential for substantial financial and operational risks, fundamentally altering the investment thesis for the company.
At the time of this filing, BLMZF was trading at $0.01 on OTC in the Trade & Services sector, with a market capitalization of approximately $6.3M. The 52-week trading range was $0.01 to $39.00. This filing was assessed with negative market sentiment and an importance score of 10 out of 10.